Hacker News new | ask | show | jobs
by tomku 4747 days ago
Their patent isn't on technique ("method" in the ruling), but on the actual cDNA sequence itself. As such, it's specific to the two BRCA genes.

Of course, that just makes it even more ridiculous.

1 comments

I guess my question is, do they still have a patent on any BRCA1/2 cDNA or only that specifically created according to their method?
According to the ruling, their patent specifies a sequence of nucleotides of cDNA independent of any method used to create them. I read that to mean that any BRCA1 or BRCA2 cDNA that matches that exact sequence would be infringing on Myriad's patent, regardless of how it was created.